Nektar Therapeutics Revenue Charts (NASDAQ:NKTR)

Add to My Stocks
$22.61 $0.51 (2.21%) NKTR stock closing price Jul 27, 2017 (Closing)
The latest 2017-Q1 Nektar Therapeutics revenue is 24.73M. Compare Nektar Therapeutics revenue chart with Avanir Pharma revenue, Wuxi Pharmatech revenue.

Nektar Therapeutics Revenue Chart

Quarterly Annual
  • Download
    • Download PNG image
    • Download JPEG image
    • Download SVG image
    • Download PDF document
Embed
Compare with
AVNR revenue
PFE revenue
PGNX revenue
RHHBY revenue
You can do annual as well as quarterly comparisons of Nektar Therapeutics net sales with its competitor companies like Avanir Pharma, Wuxi Pharmatech. Over the 5 year period Nektar Therapeutics revenue in 2015 was highest at 230.78M. In the latest quarter, NKTR revenue 2017-Q1 has changed from 37.45M to 24.73M implying a decrease of 33.97%.

Nektar Therapeutics Quarterly Revenue

* Past 5 years Range

Max NKTR Revenue $132.87M Sep, 2014
Min NKTR Revenue $18.41M Sep, 2012

Nektar Therapeutics Annual Revenue

* Past 5 years Range

Max NKTR Revenue $230.78M Dec, 2015
Min NKTR Revenue $81.19M Dec, 2012

Nektar Therapeutics Annual Revenue VS Peers

2016 2015 2014 2013 2012
Nektar Therapeutics Revenue $165.43M$230.78M$200.7M$148.92M$81.19M
Avanir Pharma Revenue --------$115.02M$75.36M$41.27M
Wuxi Pharmatech Revenue --------$674.27M$578.08M$499.91M
Pfizer Revenue $52.82B$48.85B$49.61B$51.58B$58.99B
Progenics Pharma Revenue $69.42M$8.67M$44.37M$7.86M$14.04M
Roche Holdings Revenue $53.44B$52.45B$54.57B$52.48B$50.63B
Revenue or net sales is the total amount of money that a company brings in through its various business activities before any costs or expenses are deducted. Revenue is also known as the topline or net sales or gross income. Revenue is for a specific period of time and appears as the "top line" in an income statement. By subtracting the costs or expenses from Nektar Therapeutics topline, we arrive at the bottom line for the company. Growing revenues over a period of time generally indicate that the company is in good health, however other factors need to be factored. Revenue can be calculated in two ways based on the type of accounting followed: accrual accounting or cashflow accounting. It is useful to compare Nektar Therapeutics revenue with peers Indivior topline, Sage Therapeutics topline, Pfizer topline; to see how the company is doing with respect to its peers.